aluates Reports

$ 0.0

Automative

Global Acinetobacter Infections Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: March 2025

Report Code: QYRE-Auto-L9

China Acinetobacter Infections Treatment Market Report Forecast 2021 2027

BUY CHAPTERS

Global Acinetobacter Infections Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-L9

Report

March 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen Inc

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

Acinetobacter Infections Treatment Sales Market

The global Acinetobacter Infections Treatment market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

The global Acinetobacter Infections Treatment market is strategically segmented by company, region (country), by Type, and by Pipeline. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Pipeline for 2020-2031.

Market Segmentation

Scope of Acinetobacter Infections Treatment Sales Market Report

Report Metric	Details
Report Name	Acinetobacter Infections Treatment Sales Market
By Type: (Dominant Segment vs High-Margin Innovation)	Sulbactam Carbapenems Aminoglycosides Polymyxins Tetracyclines Others
By Application: (Core Demand Driver vs Emerging Opportunity)	ETX2514 Nacubactam RG6080 Arenicin VXD-001 Small Molecule Antibiotic AR-401 mAB LCB01-0371 (PO) GN-4474 Antibacterial Antibody Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife PHARMA, Shionogi, Techulon, Tetraphase Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Acinetobacter Infections Treatment market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Carbapenems in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Nacubactam RG6080 in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Acinetobacter Infections Treatment value chain, addressing:

FAQ for this report

What is the market share of major companies in Acinetobacter Infections Treatment Sales Market?

Ans: Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

Who are the main players in the Acinetobacter Infections Treatment Sales Market report?

Ans: The main players in the Acinetobacter Infections Treatment Sales Market are Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, LegoChem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife PHARMA, Shionogi, Techulon, Tetraphase Pharmaceuticals

What are the Application segmentation covered in the Acinetobacter Infections Treatment Sales Market report?

Ans: The Applications covered in the Acinetobacter Infections Treatment Sales Market report are ETX2514, Nacubactam RG6080, Arenicin, VXD-001, Small Molecule Antibiotic, AR-401 mAB, LCB01-0371 (PO), GN-4474, Antibacterial Antibody, Others

What are the Type segmentation covered in the Acinetobacter Infections Treatment Sales Market report?

Ans: The Types covered in the Acinetobacter Infections Treatment Sales Market report are Sulbactam, Carbapenems, Aminoglycosides, Polymyxins, Tetracyclines, Others

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Sulbactam

1.2.3 Carbapenems

1.2.4 Aminoglycosides

1.2.5 Polymyxins

1.2.6 Tetracyclines

1.2.7 Others

1.3 Market by Pipeline

1.3.1 Global Market Share by Pipeline: 2020 VS 2024 VS 2031

1.3.2 ETX2514

1.3.3 Nacubactam RG6080

1.3.4 Arenicin

1.3.5 VXD-001

1.3.6 Small Molecule Antibiotic

1.3.7 AR-401 mAB

1.3.8 LCB01-0371 (PO)

1.3.9 GN-4474

1.3.10 Antibacterial Antibody

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acinetobacter Infections Treatment Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Acinetobacter Infections Treatment Revenue Market Share by Region (2020-2025)

2.4 Global Acinetobacter Infections Treatment Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Acinetobacter Infections Treatment Market Size and Prospective (2020-2031)

2.5.2 Europe Acinetobacter Infections Treatment Market Size and Prospective (2020-2031)

2.5.3 China Acinetobacter Infections Treatment Market Size and Prospective (2020-2031)

2.5.4 Japan Acinetobacter Infections Treatment Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Acinetobacter Infections Treatment Historic Market Size by Type (2020-2025)

3.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2026-2031)

3.3 Different Types Acinetobacter Infections Treatment Representative Players

4 Breakdown Data by Pipeline

4.1 Global Acinetobacter Infections Treatment Historic Market Size by Pipeline (2020-2025)

4.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2026-2031)

4.3 New Sources of Growth in Acinetobacter Infections Treatment Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Acinetobacter Infections Treatment Players by Revenue (2020-2025)

5.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Acinetobacter Infections Treatment Revenue

5.4 Global Acinetobacter Infections Treatment Market Concentration Analysis

5.4.1 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2024

5.5 Global Key Players of Acinetobacter Infections Treatment Head office and Area Served

5.6 Global Key Players of Acinetobacter Infections Treatment, Product and Application

5.7 Global Key Players of Acinetobacter Infections Treatment, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Acinetobacter Infections Treatment Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Acinetobacter Infections Treatment Market Size by Type (2020-2025)

6.1.2.2 North America Acinetobacter Infections Treatment Market Share by Type (2020-2025)

6.1.3 North America Market Size by Pipeline

6.1.3.1 North America Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)

6.1.3.2 North America Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Acinetobacter Infections Treatment Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Acinetobacter Infections Treatment Market Size by Type (2020-2025)

6.2.2.2 Europe Acinetobacter Infections Treatment Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Pipeline

6.2.3.1 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)

6.2.3.2 Europe Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Acinetobacter Infections Treatment Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Acinetobacter Infections Treatment Market Size by Type (2020-2025)

6.3.2.2 China Acinetobacter Infections Treatment Market Share by Type (2020-2025)

6.3.3 China Market Size by Pipeline

6.3.3.1 China Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)

6.3.3.2 China Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Acinetobacter Infections Treatment Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Acinetobacter Infections Treatment Market Size by Type (2020-2025)

6.4.2.2 Japan Acinetobacter Infections Treatment Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Pipeline

6.4.3.1 Japan Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025)

6.4.3.2 Japan Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

6.4.4 Japan Market Trend and Opportunities

7 Key Players Profiles

7.1 Entasis Therapeutics

7.1.1 Entasis Therapeutics Company Details

7.1.2 Entasis Therapeutics Business Overview

7.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Introduction

7.1.4 Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.1.5 Entasis Therapeutics Recent Development

7.2 Roche

7.2.1 Roche Company Details

7.2.2 Roche Business Overview

7.2.3 Roche Acinetobacter Infections Treatment Introduction

7.2.4 Roche Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.2.5 Roche Recent Development

7.3 Adenium Biotech

7.3.1 Adenium Biotech Company Details

7.3.2 Adenium Biotech Business Overview

7.3.3 Adenium Biotech Acinetobacter Infections Treatment Introduction

7.3.4 Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.3.5 Adenium Biotech Recent Development

7.4 Vaxdyn

7.4.1 Vaxdyn Company Details

7.4.2 Vaxdyn Business Overview

7.4.3 Vaxdyn Acinetobacter Infections Treatment Introduction

7.4.4 Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.4.5 Vaxdyn Recent Development

7.5 Hsiri Therapeutics

7.5.1 Hsiri Therapeutics Company Details

7.5.2 Hsiri Therapeutics Business Overview

7.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Introduction

7.5.4 Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.5.5 Hsiri Therapeutics Recent Development

7.6 Aridis Pharmaceuticals

7.6.1 Aridis Pharmaceuticals Company Details

7.6.2 Aridis Pharmaceuticals Business Overview

7.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Introduction

7.6.4 Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.6.5 Aridis Pharmaceuticals Recent Development

7.7 LegoChem Biosciences

7.7.1 LegoChem Biosciences Company Details

7.7.2 LegoChem Biosciences Business Overview

7.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Introduction

7.7.4 LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.7.5 LegoChem Biosciences Recent Development

7.8 Atterx Biotherapeutics

7.8.1 Atterx Biotherapeutics Company Details

7.8.2 Atterx Biotherapeutics Business Overview

7.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Introduction

7.8.4 Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.8.5 Atterx Biotherapeutics Recent Development

7.9 Achaogen

7.9.1 Achaogen Company Details

7.9.2 Achaogen Business Overview

7.9.3 Achaogen Acinetobacter Infections Treatment Introduction

7.9.4 Achaogen Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.9.5 Achaogen Recent Development

7.10 Peptilogics

7.10.1 Peptilogics Company Details

7.10.2 Peptilogics Business Overview

7.10.3 Peptilogics Acinetobacter Infections Treatment Introduction

7.10.4 Peptilogics Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.10.5 Peptilogics Recent Development

7.11 Sealife PHARMA

7.11.1 Sealife PHARMA Company Details

7.11.2 Sealife PHARMA Business Overview

7.11.3 Sealife PHARMA Acinetobacter Infections Treatment Introduction

7.11.4 Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.11.5 Sealife PHARMA Recent Development

7.12 Shionogi

7.12.1 Shionogi Company Details

7.12.2 Shionogi Business Overview

7.12.3 Shionogi Acinetobacter Infections Treatment Introduction

7.12.4 Shionogi Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.12.5 Shionogi Recent Development

7.13 Techulon

7.13.1 Techulon Company Details

7.13.2 Techulon Business Overview

7.13.3 Techulon Acinetobacter Infections Treatment Introduction

7.13.4 Techulon Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.13.5 Techulon Recent Development

7.14 Tetraphase Pharmaceuticals

7.14.1 Tetraphase Pharmaceuticals Company Details

7.14.2 Tetraphase Pharmaceuticals Business Overview

7.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Introduction

7.14.4 Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2020-2025)

7.14.5 Tetraphase Pharmaceuticals Recent Development

8 Acinetobacter Infections Treatment Market Dynamics

8.1 Acinetobacter Infections Treatment Industry Trends

8.2 Acinetobacter Infections Treatment Market Drivers

8.3 Acinetobacter Infections Treatment Market Challenges

8.4 Acinetobacter Infections Treatment Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen Inc

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

List of Tables

Table 1. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Acinetobacter Infections Treatment Market Size Growth by Pipeline (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Acinetobacter Infections Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Acinetobacter Infections Treatment Revenue Share by Region (2020-2025)

Table 6. Global Acinetobacter Infections Treatment Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Acinetobacter Infections Treatment Revenue Share Forecast by Region (2026-2031)

Table 8. Global Acinetobacter Infections Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2020-2025)

Table 10. Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025) & (US$ Million)

Table 14. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2020-2025)

Table 15. Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2026-2031) & (US$ Million)

Table 16. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2026-2031)

Table 17. New Sources of Growth in Acinetobacter Infections Treatment Application

Table 18. Global Acinetobacter Infections Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Acinetobacter Infections Treatment Market Share by Players (2020-2025)

Table 20. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2024)

Table 21. Ranking of Global Top Acinetobacter Infections Treatment Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Acinetobacter Infections Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Acinetobacter Infections Treatment, Headquarters and Area Served

Table 24. Global Key Players of Acinetobacter Infections Treatment, Product and Application

Table 25. Global Key Players of Acinetobacter Infections Treatment, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Acinetobacter Infections Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Acinetobacter Infections Treatment Revenue Market Share by Company (2020-2025)

Table 29. North America Acinetobacter Infections Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025) & (US$ Million)

Table 31. Europe Acinetobacter Infections Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Acinetobacter Infections Treatment Revenue Market Share by Company (2020-2025)

Table 33. Europe Acinetobacter Infections Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025) & (US$ Million)

Table 35. China Acinetobacter Infections Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Acinetobacter Infections Treatment Revenue Market Share by Company (2020-2025)

Table 37. China Acinetobacter Infections Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025) & (US$ Million)

Table 39. Japan Acinetobacter Infections Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Acinetobacter Infections Treatment Revenue Market Share by Company (2020-2025)

Table 41. Japan Acinetobacter Infections Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Acinetobacter Infections Treatment Market Size by Pipeline (2020-2025) & (US$ Million)

Table 43. Entasis Therapeutics Company Details

Table 44. Entasis Therapeutics Business Overview

Table 45. Entasis Therapeutics Acinetobacter Infections Treatment Product

Table 46. Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 47. Entasis Therapeutics Recent Development

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Acinetobacter Infections Treatment Product

Table 51. Roche Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Adenium Biotech Company Details

Table 54. Adenium Biotech Business Overview

Table 55. Adenium Biotech Acinetobacter Infections Treatment Product

Table 56. Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 57. Adenium Biotech Recent Development

Table 58. Vaxdyn Company Details

Table 59. Vaxdyn Business Overview

Table 60. Vaxdyn Acinetobacter Infections Treatment Product

Table 61. Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 62. Vaxdyn Recent Development

Table 63. Hsiri Therapeutics Company Details

Table 64. Hsiri Therapeutics Business Overview

Table 65. Hsiri Therapeutics Acinetobacter Infections Treatment Product

Table 66. Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 67. Hsiri Therapeutics Recent Development

Table 68. Aridis Pharmaceuticals Company Details

Table 69. Aridis Pharmaceuticals Business Overview

Table 70. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product

Table 71. Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 72. Aridis Pharmaceuticals Recent Development

Table 73. LegoChem Biosciences Company Details

Table 74. LegoChem Biosciences Business Overview

Table 75. LegoChem Biosciences Acinetobacter Infections Treatment Product

Table 76. LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 77. LegoChem Biosciences Recent Development

Table 78. Atterx Biotherapeutics Company Details

Table 79. Atterx Biotherapeutics Business Overview

Table 80. Atterx Biotherapeutics Acinetobacter Infections Treatment Product

Table 81. Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 82. Atterx Biotherapeutics Recent Development

Table 83. Achaogen Company Details

Table 84. Achaogen Business Overview

Table 85. Achaogen Acinetobacter Infections Treatment Product

Table 86. Achaogen Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 87. Achaogen Recent Development

Table 88. Peptilogics Company Details

Table 89. Peptilogics Business Overview

Table 90. Peptilogics Acinetobacter Infections Treatment Product

Table 91. Peptilogics Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 92. Peptilogics Recent Development

Table 93. Sealife PHARMA Company Details

Table 94. Sealife PHARMA Business Overview

Table 95. Sealife PHARMA Acinetobacter Infections Treatment Product

Table 96. Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 97. Sealife PHARMA Recent Development

Table 98. Shionogi Company Details

Table 99. Shionogi Business Overview

Table 100. Shionogi Acinetobacter Infections Treatment Product

Table 101. Shionogi Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 102. Shionogi Recent Development

Table 103. Techulon Company Details

Table 104. Techulon Business Overview

Table 105. Techulon Acinetobacter Infections Treatment Product

Table 106. Techulon Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 107. Techulon Recent Development

Table 108. Tetraphase Pharmaceuticals Company Details

Table 109. Tetraphase Pharmaceuticals Business Overview

Table 110. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product

Table 111. Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2020-2025) & (US$ Million)

Table 112. Tetraphase Pharmaceuticals Recent Development

Table 113. Acinetobacter Infections Treatment Market Trends

Table 114. Acinetobacter Infections Treatment Market Drivers

Table 115. Acinetobacter Infections Treatment Market Challenges

Table 116. Acinetobacter Infections Treatment Market Restraints

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Acinetobacter Infections Treatment Product Picture

Figure 2. Global Acinetobacter Infections Treatment Market Share by Type: 2024 VS 2031

Figure 3. Sulbactam Features

Figure 4. Carbapenems Features

Figure 5. Aminoglycosides Features

Figure 6. Polymyxins Features

Figure 7. Tetracyclines Features

Figure 8. Others Features

Figure 9. Global Acinetobacter Infections Treatment Market Share by Pipeline: 2024 VS 2031

Figure 10. ETX2514

Figure 11. Nacubactam RG6080

Figure 12. Arenicin

Figure 13. VXD-001

Figure 14. Small Molecule Antibiotic

Figure 15. AR-401 mAB

Figure 16. LCB01-0371 (PO)

Figure 17. GN-4474

Figure 18. Antibacterial Antibody

Figure 19. Acinetobacter Infections Treatment Report Years Considered

Figure 20. Global Acinetobacter Infections Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Acinetobacter Infections Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Acinetobacter Infections Treatment Revenue Market Share by Region: 2020 VS 2024

Figure 23. North America Acinetobacter Infections Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Europe Acinetobacter Infections Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. China Acinetobacter Infections Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Japan Acinetobacter Infections Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. Global Acinetobacter Infections Treatment Market Share by Players in 2024

Figure 28. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2024)

Figure 29. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2024

Figure 30. North America Acinetobacter Infections Treatment Market Share by Type (2020-2025)

Figure 31. North America Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

Figure 32. Europe Acinetobacter Infections Treatment Market Share by Type (2020-2025)

Figure 33. Europe Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

Figure 34. China Acinetobacter Infections Treatment Market Share by Type (2020-2025)

Figure 35. China Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

Figure 36. Japan Acinetobacter Infections Treatment Market Share by Type (2020-2025)

Figure 37. Japan Acinetobacter Infections Treatment Market Share by Pipeline (2020-2025)

Figure 38. Entasis Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 39. Roche Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 40. Adenium Biotech Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 41. Vaxdyn Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 42. Hsiri Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 43. Aridis Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 44. LegoChem Biosciences Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 45. Atterx Biotherapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 46. Achaogen Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 47. Peptilogics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 48. Sealife PHARMA Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 49. Shionogi Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 50. Techulon Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 51. Tetraphase Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Acetobacter Market Research Report 2025

Multidrug Resistant Bacteria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gram Negative lnfections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Perinatal Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Aquaculture Bacterial Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inner Ear Infection Treatment Market Research Report 2025

Mycobacterium Abscessus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antimicrobial Technology Market Research Report 2024

Intra amniotic Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibiotic Resistance Market Insights Forecast to 2030

Global Staphylococcal Infection Drugs Market Insights Forecast to 2030

Dental Infection Prevention Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Infection Drugs Market Insights Forecast to 2030

Global Mediastinitis Treatment Market Research Report 2024

Global Ceftriaxone Market Research Report 2025

Global Biological Treatment System Market Research Report 2025

Global Industrial Antimicrobial Agent Market Research Report 2025

Global Microbial Antibacterial Drugs Market Research Report 2024

Global Antimicrobial Barrier Dressing Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions